SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-034543
Filing Date
2022-10-31
Accepted
2022-10-31 15:20:29
Documents
1
Period of Report
2022-10-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5963
  Complete submission text file 0000899243-22-034543.txt   7978
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Reporting) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 221345693

Mailing Address ARA HILL TOP BUILDING, UNIT A-5 PLETTERIJWEG OOST 1, CURACAO WILLEMSTAD P8 000000
Business Address
BIOTECH GROWTH N V (Reporting) CIK: 0001259869 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 221345694

Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)